Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Active Pharmaceutical Ingredients(API) market report explains the definition, types, applications, major countries, and major players of the Active Pharmaceutical Ingredients(API) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Lonza Group
DSM
Jiangsu Hengrui Medicine
AbbVie
Eli Lilly and Company
Johnson & Johnson
Biocon
Merck & Co
Sun Pharmaceutical Industries
Sanofi
Shandong Lukang Pharmaceutical
GlaxoSmithKline
Hisun Pharmacy
Lupin
Huahai Pharmaceutical
Pfizer
Shandong Xinhua Pharmaceutical
Novartis International
Bristol-Myers Squibb
Teva Pharmaceutical
Haerbin Pharmaceutical Group
North China Pharmaceutical Group
Boehringer Ingelheim
Bayer
Aurobindo Pharma
By Type:
Synthetic APIs
Biotech APIs
By End-User:
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders
Endocrinology
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Active Pharmaceutical Ingredients(API) Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Active Pharmaceutical Ingredients(API) Outlook to 2028- Original Forecasts
-
2.2 Active Pharmaceutical Ingredients(API) Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Active Pharmaceutical Ingredients(API) Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Active Pharmaceutical Ingredients(API) Market- Recent Developments
-
6.1 Active Pharmaceutical Ingredients(API) Market News and Developments
-
6.2 Active Pharmaceutical Ingredients(API) Market Deals Landscape
7 Active Pharmaceutical Ingredients(API) Raw Materials and Cost Structure Analysis
-
7.1 Active Pharmaceutical Ingredients(API) Key Raw Materials
-
7.2 Active Pharmaceutical Ingredients(API) Price Trend of Key Raw Materials
-
7.3 Active Pharmaceutical Ingredients(API) Key Suppliers of Raw Materials
-
7.4 Active Pharmaceutical Ingredients(API) Market Concentration Rate of Raw Materials
-
7.5 Active Pharmaceutical Ingredients(API) Cost Structure Analysis
-
7.5.1 Active Pharmaceutical Ingredients(API) Raw Materials Analysis
-
7.5.2 Active Pharmaceutical Ingredients(API) Labor Cost Analysis
-
7.5.3 Active Pharmaceutical Ingredients(API) Manufacturing Expenses Analysis
8 Global Active Pharmaceutical Ingredients(API) Import and Export Analysis (Top 10 Countries)
-
8.1 Global Active Pharmaceutical Ingredients(API) Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Active Pharmaceutical Ingredients(API) Export by Region (Top 10 Countries) (2017-2028)
9 Global Active Pharmaceutical Ingredients(API) Market Outlook by Types and Applications to 2022
-
9.1 Global Active Pharmaceutical Ingredients(API) Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Synthetic APIs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Biotech APIs Consumption and Growth Rate (2017-2022)
-
9.2 Global $Active Pharmaceutical Ingredients(API) Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Cardiovascular Disease Consumption and Growth Rate (2017-2022)
-
9.2.4 Global CNS and Neurological Disorders Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Endocrinology Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Active Pharmaceutical Ingredients(API) Market Analysis and Outlook till 2022
-
10.1 Global Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.2.2 Canada Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.2.3 Mexico Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.3.2 UK Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.3.3 Spain Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.3.4 Belgium Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.3.5 France Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.3.6 Italy Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.3.7 Denmark Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.3.8 Finland Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.3.9 Norway Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.3.10 Sweden Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.3.11 Poland Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.3.12 Russia Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.3.13 Turkey Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.4.2 Japan Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.4.3 India Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.4.4 South Korea Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.4.5 Pakistan Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.4.6 Bangladesh Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.4.7 Indonesia Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.4.8 Thailand Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.4.9 Singapore Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.4.10 Malaysia Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.4.11 Philippines Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.4.12 Vietnam Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.5.2 Colombia Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.5.3 Chile Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.5.4 Argentina Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.5.5 Venezuela Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.5.6 Peru Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.5.7 Puerto Rico Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.5.8 Ecuador Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.6.2 Kuwait Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.6.3 Oman Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.6.4 Qatar Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.6.5 Saudi Arabia Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.6.6 United Arab Emirates Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.7.2 South Africa Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.7.3 Egypt Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.7.4 Algeria Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
-
10.8.2 New Zealand Active Pharmaceutical Ingredients(API) Consumption (2017-2022)
11 Global Active Pharmaceutical Ingredients(API) Competitive Analysis
-
11.1 Lonza Group
-
11.1.1 Lonza Group Company Details
-
11.1.2 Lonza Group Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Lonza Group Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.1.4 Lonza Group Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 DSM
-
11.2.1 DSM Company Details
-
11.2.2 DSM Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 DSM Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.2.4 DSM Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Jiangsu Hengrui Medicine
-
11.3.1 Jiangsu Hengrui Medicine Company Details
-
11.3.2 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.3.4 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 AbbVie
-
11.4.1 AbbVie Company Details
-
11.4.2 AbbVie Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 AbbVie Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.4.4 AbbVie Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Eli Lilly and Company
-
11.5.1 Eli Lilly and Company Company Details
-
11.5.2 Eli Lilly and Company Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Eli Lilly and Company Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.5.4 Eli Lilly and Company Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Johnson & Johnson
-
11.6.1 Johnson & Johnson Company Details
-
11.6.2 Johnson & Johnson Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Johnson & Johnson Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.6.4 Johnson & Johnson Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Biocon
-
11.7.1 Biocon Company Details
-
11.7.2 Biocon Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Biocon Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.7.4 Biocon Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Merck & Co
-
11.8.1 Merck & Co Company Details
-
11.8.2 Merck & Co Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Merck & Co Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.8.4 Merck & Co Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Sun Pharmaceutical Industries
-
11.9.1 Sun Pharmaceutical Industries Company Details
-
11.9.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.9.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Sanofi
-
11.10.1 Sanofi Company Details
-
11.10.2 Sanofi Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Sanofi Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.10.4 Sanofi Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Shandong Lukang Pharmaceutical
-
11.11.1 Shandong Lukang Pharmaceutical Company Details
-
11.11.2 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.11.4 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 GlaxoSmithKline
-
11.12.1 GlaxoSmithKline Company Details
-
11.12.2 GlaxoSmithKline Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 GlaxoSmithKline Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.12.4 GlaxoSmithKline Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Hisun Pharmacy
-
11.13.1 Hisun Pharmacy Company Details
-
11.13.2 Hisun Pharmacy Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Hisun Pharmacy Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.13.4 Hisun Pharmacy Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Lupin
-
11.14.1 Lupin Company Details
-
11.14.2 Lupin Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Lupin Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.14.4 Lupin Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Huahai Pharmaceutical
-
11.15.1 Huahai Pharmaceutical Company Details
-
11.15.2 Huahai Pharmaceutical Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.15.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Pfizer
-
11.16.1 Pfizer Company Details
-
11.16.2 Pfizer Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Pfizer Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.16.4 Pfizer Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Shandong Xinhua Pharmaceutical
-
11.17.1 Shandong Xinhua Pharmaceutical Company Details
-
11.17.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.17.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Novartis International
-
11.18.1 Novartis International Company Details
-
11.18.2 Novartis International Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Novartis International Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.18.4 Novartis International Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Bristol-Myers Squibb
-
11.19.1 Bristol-Myers Squibb Company Details
-
11.19.2 Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.19.4 Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Teva Pharmaceutical
-
11.20.1 Teva Pharmaceutical Company Details
-
11.20.2 Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.20.4 Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Haerbin Pharmaceutical Group
-
11.21.1 Haerbin Pharmaceutical Group Company Details
-
11.21.2 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.21.4 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.21.5 Recent Research and Development Strategies
-
11.22 North China Pharmaceutical Group
-
11.22.1 North China Pharmaceutical Group Company Details
-
11.22.2 North China Pharmaceutical Group Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.22.3 North China Pharmaceutical Group Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.22.4 North China Pharmaceutical Group Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.22.5 Recent Research and Development Strategies
-
11.23 Boehringer Ingelheim
-
11.23.1 Boehringer Ingelheim Company Details
-
11.23.2 Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.23.3 Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.23.4 Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.23.5 Recent Research and Development Strategies
-
11.24 Bayer
-
11.24.1 Bayer Company Details
-
11.24.2 Bayer Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.24.3 Bayer Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.24.4 Bayer Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.24.5 Recent Research and Development Strategies
-
11.25 Aurobindo Pharma
-
11.25.1 Aurobindo Pharma Company Details
-
11.25.2 Aurobindo Pharma Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
11.25.3 Aurobindo Pharma Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
11.25.4 Aurobindo Pharma Active Pharmaceutical Ingredients(API) Product Portfolio
-
11.25.5 Recent Research and Development Strategies
12 Global Active Pharmaceutical Ingredients(API) Market Outlook by Types and Applications to 2028
-
12.1 Global Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Synthetic APIs Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Biotech APIs Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Cardiovascular Disease Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global CNS and Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Active Pharmaceutical Ingredients(API) Market Analysis and Outlook to 2028
-
13.1 Global Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.2.2 Canada Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.2.3 Mexico Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.3.2 UK Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.3.3 Spain Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.3.4 Belgium Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.3.5 France Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.3.6 Italy Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.3.7 Denmark Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.3.8 Finland Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.3.9 Norway Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.3.10 Sweden Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.3.11 Poland Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.3.12 Russia Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.3.13 Turkey Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.4.2 Japan Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.4.3 India Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.4.4 South Korea Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.4.8 Thailand Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.4.9 Singapore Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.4.11 Philippines Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.5.2 Colombia Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.5.3 Chile Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.5.4 Argentina Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.5.6 Peru Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.6.3 Oman Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.6.4 Qatar Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.7.2 South Africa Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.7.3 Egypt Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.7.4 Algeria Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Active Pharmaceutical Ingredients(API) Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Active Pharmaceutical Ingredients(API)
-
Figure of Active Pharmaceutical Ingredients(API) Picture
-
Table Global Active Pharmaceutical Ingredients(API) Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Active Pharmaceutical Ingredients(API) Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Synthetic APIs Consumption and Growth Rate (2017-2022)
-
Figure Global Biotech APIs Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Disease Consumption and Growth Rate (2017-2022)
-
Figure Global CNS and Neurological Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Endocrinology Consumption and Growth Rate (2017-2022)
-
Figure Global Active Pharmaceutical Ingredients(API) Consumption by Country (2017-2022)
-
Table North America Active Pharmaceutical Ingredients(API) Consumption by Country (2017-2022)
-
Figure United States Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Canada Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Mexico Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Table Europe Active Pharmaceutical Ingredients(API) Consumption by Country (2017-2022)
-
Figure Germany Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure UK Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Spain Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Belgium Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure France Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Italy Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Denmark Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Finland Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Norway Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Sweden Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Poland Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Russia Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Turkey Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Table APAC Active Pharmaceutical Ingredients(API) Consumption by Country (2017-2022)
-
Figure China Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Japan Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure India Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure South Korea Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Thailand Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Singapore Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Philippines Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Table South America Active Pharmaceutical Ingredients(API) Consumption by Country (2017-2022)
-
Figure Brazil Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Colombia Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Chile Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Argentina Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Peru Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Table GCC Active Pharmaceutical Ingredients(API) Consumption by Country (2017-2022)
-
Figure Bahrain Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Oman Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Qatar Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Table Africa Active Pharmaceutical Ingredients(API) Consumption by Country (2017-2022)
-
Figure Nigeria Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure South Africa Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Egypt Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure Algeria Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Table Oceania Active Pharmaceutical Ingredients(API) Consumption by Country (2017-2022)
-
Figure Australia Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Active Pharmaceutical Ingredients(API) Consumption and Growth Rate (2017-2022)
-
Table Lonza Group Company Details
-
Table Lonza Group Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lonza Group Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Lonza Group Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table DSM Company Details
-
Table DSM Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table DSM Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table DSM Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Jiangsu Hengrui Medicine Company Details
-
Table Jiangsu Hengrui Medicine Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jiangsu Hengrui Medicine Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Jiangsu Hengrui Medicine Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table AbbVie Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Eli Lilly and Company Company Details
-
Table Eli Lilly and Company Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Eli Lilly and Company Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Johnson & Johnson Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Biocon Company Details
-
Table Biocon Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Biocon Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Merck & Co Company Details
-
Table Merck & Co Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Merck & Co Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Sun Pharmaceutical Industries Company Details
-
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Sanofi Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Shandong Lukang Pharmaceutical Company Details
-
Table Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table GlaxoSmithKline Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Hisun Pharmacy Company Details
-
Table Hisun Pharmacy Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hisun Pharmacy Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Hisun Pharmacy Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Lupin Company Details
-
Table Lupin Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Lupin Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Huahai Pharmaceutical Company Details
-
Table Huahai Pharmaceutical Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Huahai Pharmaceutical Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Huahai Pharmaceutical Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Pfizer Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Shandong Xinhua Pharmaceutical Company Details
-
Table Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Novartis International Company Details
-
Table Novartis International Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis International Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Novartis International Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Bristol-Myers Squibb Company Details
-
Table Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Teva Pharmaceutical Company Details
-
Table Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Haerbin Pharmaceutical Group Company Details
-
Table Haerbin Pharmaceutical Group Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Haerbin Pharmaceutical Group Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Haerbin Pharmaceutical Group Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table North China Pharmaceutical Group Company Details
-
Table North China Pharmaceutical Group Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table North China Pharmaceutical Group Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table North China Pharmaceutical Group Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Bayer Active Pharmaceutical Ingredients(API) Product Portfolio
-
Table Aurobindo Pharma Company Details
-
Table Aurobindo Pharma Active Pharmaceutical Ingredients(API) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo Pharma Active Pharmaceutical Ingredients(API) Main Business and Markets Served
-
Table Aurobindo Pharma Active Pharmaceutical Ingredients(API) Product Portfolio
-
Figure Global Synthetic APIs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biotech APIs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CNS and Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Active Pharmaceutical Ingredients(API) Consumption Forecast by Country (2022-2028)
-
Table North America Active Pharmaceutical Ingredients(API) Consumption Forecast by Country (2022-2028)
-
Figure United States Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Active Pharmaceutical Ingredients(API) Consumption Forecast by Country (2022-2028)
-
Figure Germany Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Active Pharmaceutical Ingredients(API) Consumption Forecast by Country (2022-2028)
-
Figure China Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Active Pharmaceutical Ingredients(API) Consumption Forecast by Country (2022-2028)
-
Figure Brazil Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Active Pharmaceutical Ingredients(API) Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Active Pharmaceutical Ingredients(API) Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Active Pharmaceutical Ingredients(API) Consumption Forecast by Country (2022-2028)
-
Figure Australia Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Active Pharmaceutical Ingredients(API) Consumption Forecast and Growth Rate (2022-2028)
-
